Evaluation of serum prostate-specific antigen levels after postoperative radiation therapy for pathologic stage T3, No prostate cancer

Mayo Clinic Proceedings

Volumn 71, Issue 3, 1996, Pages 242-248

  Buskirk, Steven J ^a   Schild, Steven E ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; MALE; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; TREATMENT OUTCOME;

EID: 0029878285     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/71.3.242     Document Type: Article

References (31)

1. Anscher MS, Prosnitz LR. Multivariate analysis of factors predicting local relapse after radical prostatectomy-possible indications for postoperative radiotherapy. Int J Radiât Oncol BiolPhys 1991; 21:941-947
2. Jewett HJ, Eggleston JC, Yawn DH. Radical prostatectomy in the management of carcinoma of the prostate: probable causes of some therapeutic failures. J Urol 1972; 107:10341040
3. Jewett HJ. The present status of radical prostatectomy for stages A and B prostatic cancer. Urol Clin North Am 1975 Feb; 2:105-124
4. Myers RP, Fleming TR. Course of localized adenocarcinoma of the prostate treated by radical prostatectomy. Prostate 1983; 4:461-472
5. Schellhammer PF. Radical prostatectomy for carcinoma of the prostate and 15 year analysis of survival and local control [abstract]. J Urol 1986; 135(No. 4, Part 2):247A
6. Schroeder FH, Belt E. Carcinoma of the prostate: a study of 213 patients with stage C tumors treated by total perineal prostatectomy. J Urol 1975; 114:257-260
7. Anscher MS, Prosnitz LR. Postoperative radiotherapy for patients with carcinoma of the prostate undergoing radical prostatectomy with positive surgical margins, seminal vesicle involvement and/or penetration through the capsule. J Urol 1987; 138:1407-1412
8. Oesterling JE. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 1991; 145:907-923
9. Lange PH, Ercole CJ, Lightner DJ, Fraley EE, Vessella R. The value of serum prostate specific antigen determinations before and after radical prostatectomy. J Urol 1989; 141:873-879
10. Gibbons RP, Cole BS, Richardson RG, Correa RJ Jr, Brannen GE, Mason JT, et al. Adjuvant radiotherapy following radical prostatectomy: results and complications. J Urol 1986; 135:65-68
11. Hanks GE, Dawson AK. The role of external beam radiation therapy after prostatectomy for prostate cancer. Cancer 1986; 58:2406-2410
12. Ray GR, Bagshaw MA, Freiha F. External beam radiation salvage for residual or recurrent local tumor following radical prostatectomy. JUrol 1984; 132:926-930
13. Rosen EM, Cassady JR, Connolly J, Chaffey JT. Radiotherapy for localized prostate carcinoma. Int J Radiât Oncol BiolPhys 1984; 10:2201-2210
14. Anscher MS, Prosnitz LR. Radiotherapy vs. hormonal therapy for the management of locally recurrent prostate cancer following radical prostatectomy. Int J Radiât Oncol Biol Phys 1989; 17:953-958
15. Forman JD, Wharam MD, Lee DJ, Zinreich ES, Order SE. Definitive radiotherapy following prostatectomy: results and complications. Int J Radiât Oncol Biol Phys 1986; 12:185189
16. Ray GR, Cassady JR, Bagshaw MA. External-beam megavoltage radiation therapy in the treatment of post-radical prostatectomy residual or recurrent tumor: preliminary results. JUrol 1975; 114:98-101
17. Pilepich MV, Walz BJ, Baglan RJ. Postoperativeirradiation in carcinoma of the prostate. Int J Radiât Oncol Biol Phys 1984; 10:1869-1873
18. Wang MC, Valenzuela LA, Murphy GP, Chu TM. Purification of a human prostate specific antigen. Invest Urol 1979; 17:159-163
19. Nadji M, Tabei SZ, Castro A, Chu TM, Murphy GP, Wang MC, et al. Prostate-specific antigen: an immunohistologic marker for prostatic neoplasms. Cancer 1981; 48:1229-1232
20. Morgan WR, Zincke H, Rainwater LM, Myers RP, Klee GG. Prostate specific antigen values after radical retropubic prostatectomy for adenocarcinoma of the prostate: impact of adjuvant treatment (hormonal and radiation). J Urol 1991; 145:319-323
21. Robinow JS, Schild SE, Tomera KM, Wolfe JT, Buskirk SJ. Postoperative prostate specific antigen levels in pathologic stage C adenocarcinoma of the prostate in patients treated with radical prostatectomy alone [abstract]. Int J Radiât Oncol Biol Phys 1993; 27(Suppl l):228-229
22. Schild SE, Wong WW, Grado GL, Buskirk SJ, Robinow JS, Frick LM, et al. Radiotherapy for isolated increases in serum prostate-specific antigen levels after radical prostatectomy. Mayo Clin Proc 1994; 69:613-619
23. Frazier HA, Robertson JE, Humphrey PA, Paulson DF. Is prostate specific antigen of clinical importance in evaluating outcome after radical prostatectomy? J Urol 1993; 149:516518
24. Partin AW, Borland RN, Epstein JI, Brendler CB. Influence of wide excision of the neurovascular bundle(s) on prognosis in men with clinically localized prostate cancer with established capsular penetration. JUrol 1993; 150:142-146
25. Epstein JI, Carmichael MJ, Pizov G, Walsh PC. Influence of capsular penetration on progression following radical prostatectomy: a study of 196 cases with long-term followup. JUrol 1993; 150:135-141
26. Epstein JI, Carmichael M, Walsh PC. Adenocarcinoma of the prostate invading the seminal vesicle: definition and relation of tumor volume, grade and margins of resection to prognosis. JUrol 1993; 149:1040-1045
27. Zietman AL, Edelstein RA, Coen JJ, Babayan RK, Krane RJ. Radical prostatectomy for adenocarcinoma of the prostate: the influence of preoperative and pathologic findings on biochemical disease-free outcome. Urology 1994; 43:828833
28. Hudson MA, Catalona WJ. Effect of adjuvant radiation therapy on prostate specific antigen following radical prostatectomy. JUrol 1990; 143:1174-1177
29. Stein A, deKernion JB, Dorey F, Smith RB. Adjuvant radiotherapy in patients post-radical prostatectomy with tumor extending through capsule or positive seminal vesicles. Urology 1992; 39:59-62
30. Freeman JA, Lieskovsky G, Cook DW, Petrovich Z, Chen S, Groshen S, et al. Radical retropubic prostatectomy and postoperative adjuvant radiation for pathological stage C (PcNO) prostate cancer from 1976 to 1989: intermediate findings. J Urol 1993; 149:1029-1034
31. Zietman AL, Coen JJ, Shipley WU, Althausen AF. Adjuvant irradiation after radical prostatectomy for adenocarcinoma of prostate: analysis of freedom from PSA failure. Urology 1993; 42:292-298